Taken together, our data supports the notion of an enhancer hijacking event by which TF MNX1 is ectopically activated in the AML cell line GDM-1, and we propose a hematopoietic enhancer, E1, located in AHI1, as being responsible for MNX1 activation. The gene discussed is TF; the disease is acute myeloid leukemia.